These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 26308080

  • 1. Variable pharmacokinetics of extended interval tobramycin or gentamicin among critically ill patients undergoing continuous venovenous hemofiltration.
    Chuk AC, Saeed F, Kousar N, Burrill S, Barns B, Rickrode G, Fu J, Katrych O, Saunders-Hao P, Block C, Lahey T.
    Clin Nephrol; 2015 Oct; 84(4):214-21. PubMed ID: 26308080
    [Abstract] [Full Text] [Related]

  • 2. Continuous arteriovenous hemofiltration of aminoglycoside antibiotics in critically ill patients.
    Zarowitz BJ, Anandan JV, Dumler F, Jayashankar J, Levin N.
    J Clin Pharmacol; 1986 Oct; 26(8):686-9. PubMed ID: 3793961
    [Abstract] [Full Text] [Related]

  • 3. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE, Mouton JW, Gyssens IC, Verbrugh HA, Bruining HA.
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [Abstract] [Full Text] [Related]

  • 4. Population pharmacokinetics of aminoglycosides in critically ill trauma patients on once-daily regimens.
    Barletta JF, Johnson SB, Nix DE, Nix LC, Erstad BL.
    J Trauma; 2000 Nov; 49(5):869-72. PubMed ID: 11086778
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Suboptimal aminoglycoside dosing in critically ill patients.
    Rea RS, Capitano B, Bies R, Bigos KL, Smith R, Lee H.
    Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Monitoring of a single post-infusion blood sample to estimate the actual peak and trough concentration of tobramycin in critically ill patients.
    Reimann IR, Meier-Hellmann A, Traut T, Reinhart K, Hoffmann A.
    Exp Toxicol Pathol; 2003 Jun; 54(5-6):493-8. PubMed ID: 12877363
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacokinetic outcomes of a simplified, weight-based, extended-interval gentamicin dosing protocol in critically ill neonates.
    Hoff DS, Wilcox RA, Tollefson LM, Lipnik PG, Commers AR, Liu M.
    Pharmacotherapy; 2009 Nov; 29(11):1297-305. PubMed ID: 19857147
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The use of extended-interval aminoglycoside dosing strategies for the treatment of moderate-to-severe infections encountered in critically ill surgical patients.
    Mueller EW, Boucher BA.
    Surg Infect (Larchmt); 2009 Dec; 10(6):563-70. PubMed ID: 20035611
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.